Treatment with molecular shipping containers called extracellular vesicles, loaded with a signaling molecule called cAMP, reduced the severity of pulmonary hypertension (PH) in a rat model of the disease, a new study reports. The data indicated that these packages of signaling molecules, which they dubbed cAMP-EVs, reduced the abnormal…